StockFin.ai Try Free →

Navin Fluorine International Limited (NAVINFLUOR)

Chemicals · Chemicals & Petrochemicals · NSE · Updated 16 June 2026

₹7,287 ↑ 61.45% (1Y)

🎯 Key Takeaways

Navin Fluorine International is transitioning from a high-growth phase into a capital-intensive expansion stage, with management actively scaling specialty and high-performance polymer (HPP) segments to capture structural demand tailwinds. The company is leveraging strong profitability, robust cash flows, and strategic capex to drive margin expansion and capacity gains, positioning for sustained outperformance in specialty chemicals.
Revenue grew 16.9% QoQ to ₹606 in Q3FY25.
⚠️ Execution risk around timely commissioning of HFCMPP and Chemours projects by Q3 and end June/early July FY27, respectively, which are critical for ma

Market Cap

₹35,894

P/E Ratio

131.5

Div Yield

0.00%

Promoter

0.0%

✨ Ask AI About NAVINFLUOR 📊 Interactive Charts

📖 The Story

Navin Fluorine International is transitioning from a high-growth phase into a capital-intensive expansion stage, with management actively scaling specialty and high-performance polymer (HPP) segments to capture structural demand tailwinds. The company is leveraging strong profitability, robust cash flows, and strategic capex to drive margin expansion and capacity gains, positioning for sustained outperformance in specialty chemicals.

📰 What's Happening

In Q4 FY26, Navin Fluorine delivered 34% YoY revenue growth to Rs. 937.7 crores and 124% YoY PAT growth, driven by 35%+ growth in Specialty Chemicals and 45%+ in HPP segments. Management highlighted 80% YoY EBITDA growth, 34.2% EBITDA margin expansion (up 875 bps), and 118% YoY growth in Operating PBT to Rs. 251.0 crores. The company declared a final dividend of Rs. 8.60 per share (430% of face value), subject to AGM approval, and reappointed Vishad P. Mafatlal as Executive Chairman for five years. Capex of Rs. 236.5 crores is underway for HFCMPP capacity expansion targeting commissioning by Q3 FY27, alongside Rs. 75 crores for MPP de-bottlenecking and 15,000 MTPA R32 capacity addition. Order visibility remains strong, with management targeting 70-75% capacity utilization in FY27 and 30% full-year margin guidance.

Source: Stock Announcements

📊 Quarterly Results (₹ Cr)

Metric	Q4FY23	Q1FY24	Q2FY24	Q3FY24	Q4FY24	Q1FY25	Q2FY25	Q3FY25
Revenue	697	491	472	502	602	524	519	606
Operating Profit	206	123	121	140	123	111	119	158
OPM %	28.9%	23.3%	20.8%	15.1%	18.3%	19.2%	20.7%	24.3%
Net Profit	136	62	61	78	70	51	59	84
EPS	₹27.51	₹12.41	₹12.22	₹15.74	₹14.20	₹10.33	₹11.86	₹16.86

Revenue has grown consistently over the past four quarters, with YoY growth accelerating to 34% in Q4 FY26 from 28.9% in Q4 FY23, while operating margins have expanded significantly from 18.3% in Q4 FY24 to 34.2% in Q4 FY26, reflecting operational leverage and pricing power. Profitability metrics show NP growth of 124% YoY in Q4 FY26, supported by margin expansion and a one-time Rs. 11.91 crore reversal of labor law liabilities. EPS rose to Rs. 16.86 in Q3FY25 from Rs. 10.33 in Q1FY25, indicating strong earnings momentum. The company has maintained healthy working capital (74 days) and generated robust cash flows, enabling internal funding of capex without external debt, as evidenced by net debt to equity of 0.01x and ROCE of 21%.

🔮 Management Outlook & What's Next

Management expects EBITDA margin to sustain at 30% for FY27, with full-year margin guidance of 30% and capacity utilization targeted at 70-75%. The Chemours project is on track for completion by end June/early July FY27, and the HFCMPP expansion will add 32 MPP capacity. Management emphasized strong order visibility and pricing resilience amid raw material inflation, with no supply disruptions reported. Capex is fully funded internally, and the company is focused on scaling specialty and CDMO segments to drive structural margin improvement and capture higher-growth end-markets.

Extracted from official company announcements. Not StockFin.ai's opinion.

⚖️ Peer Comparison — Chemicals & Petrochemicals

Company	MCap (₹ Cr)	P/E	ROCE	ROE	D/E
Solar Industries India Limited	1.57 L Cr	132.3	—	—	—
Pidilite Industries Limited	1.49 L Cr	75.7	—	—	—
SRF Limited	79,723	69.5	—	—	—
Linde India Limited	62,701	141.9	—	—	—
Gujarat Fluorochemicals Limited	40,793	89.6	—	—	—
Navin Fluorine International Limited	35,894	131.5	—	—	—
Himadri Speciality Chemical Limited	30,071	56.6	—	—	—
Deepak Nitrite Limited	24,911	33.3	—	—	—
Atul Limited	20,904	48.8	—	—	—
Tata Chemicals Limited	19,079	-47.1	—	—	—

🔗 Peer Stock Analyses

SOLARINDS PIDILITIND SRF LINDEINDIA FLUOROCHEM

⚠️ Risk Factors

1. Execution risk around timely commissioning of HFCMPP and Chemours projects by Q3 and end June/early July FY27, respectively, which are critical for margin expansion targets. 2. Margin sustainability amid rising raw material costs and competitive pricing pressures in specialty chemicals, despite current pricing power. 3. Regulatory and compliance risks related to labor law changes and environmental norms, though no immediate liabilities are pending. 4. Market concentration risk in HPP and specialty segments, which are capital-intensive and vulnerable to cyclical demand shifts in downstream industries like refrigerants and polymers.

📋 Recent Filings

🧠 Analyst's Read

Navin Fluorine is executing a clear capital deployment strategy to scale high-margin specialty and HPP businesses, supported by strong financial performance and shareholder-friendly capital returns. Investors should monitor project commissioning timelines and margin trajectory in FY27, as near-term growth hinges on successful execution of the current capex cycle and sustained demand in specialty chemicals.

Based on filing content and financial data. Not a recommendation.

✨ Deep Dive with AI on NAVINFLUOR

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-06-16.